MYC and diffuse large B-cell lymphoma: JQ1, I-BET, and OTX015 can significantly reduce the proliferation of MYC in diffuse large B-cell lymphoma (DLBCL) by targeting double-hit lymphoma (DHL)/triple-hit lymphoma (THL) [83].